Authors:
HAYWARD A
AMBRUSO D
BATTAGLIA F
DONLON T
EDDELMAN K
GILLER R
HOBBINS J
HSIA YE
QUINONES R
SHPALL E
TRACHTENBERG E
GIARDINA P
Citation: A. Hayward et al., MICROCHIMERISM AND TOLERANCE FOLLOWING INTRAUTERINE TRANSPLANTATION AND TRANSFUSION FOR ALPHA-THALASSEMIA-1, Fetal diagnosis and therapy, 13(1), 1998, pp. 8-14
Authors:
GREER G
FRANKLIN W
HAMI L
WILLIAMS S
JONES K
STOLZ J
EMMERMAN J
SHPALL E
Citation: G. Greer et al., A CLONOGENIC CULTURE METHOD FOR THE IDENTIFICATION OF BREAST-CANCER CELLS IN MARROW ASPIRATES OF PATIENTS RECEIVING HIGH-DOSE CHEMOTHERAPY, Blood, 88(10), 1996, pp. 996-996
Authors:
HOGAN C
SHPALL E
HELM K
HAMI L
MCNIECE I
KELLER G
Citation: C. Hogan et al., ENGRAFTMENT AND DEVELOPMENT OF HUMAN CD34(-ENRICHED CELLS FROM G-MOBILIZED PERIPHERAL-BLOOD IN NOD())LTSZ-SCID/SCID (NOD/SCID) MICE/, Blood, 88(10), 1996, pp. 2379-2379
Authors:
BRIDDELL R
STONEY G
SCHUSTER L
KERN B
ZILM K
GLASPY J
SHPALL E
LEMAISTRE F
MCNIECE IK
Citation: R. Briddell et al., PRIMITIVE HEMATOPOIETIC PROGENITOR CELLS IN PERIPHERAL-BLOOD HARVESTSOF PATIENTS MOBILIZED WITH RHSCF PLUS RHG-CSF, Experimental hematology, 23(8), 1995, pp. 751-751
Authors:
MCNIECE I
BRIDDELL R
RECKTENWALD D
PHIWILSON J
STONEY G
SHPALL E
MILTENYI S
Citation: I. Mcniece et al., LARGE-SCALE ISOLATION OF CD34 EXPRESSING CELLS USING THE AMGEN CELL-SEPARATION DEVICE RESULTS IN HIGH-LEVELS OF PURITY AND RECOVERY, Experimental hematology, 23(8), 1995, pp. 806-806
Authors:
CHAMPLIN R
BALL E
HOLLAND K
LEMAISTRE CF
JACOBS C
SHPALL E
Citation: R. Champlin et al., IMPORTANCE OF CELL DOSE WITH CD34-SELECTED AUTOLOGOUS MARROW TRANSPLANTS - RESULTS OF A CONTROLLED TRIAL, Blood, 86(10), 1995, pp. 1159-1159
Authors:
KELLER G
HOGAN C
MCBURNEY E
HAMI L
HELM K
SHULTZ L
DICK J
MCNIECE I
SHPALL E
Citation: G. Keller et al., TRANSPLANTATION OF CD34(-CORD BLOOD PROGENITOR CELLS INTO NONOBESE DIABETIC (NOD)() HUMAN (HU) UMBILICAL)SEVERS COMBINED IMMUNODEFICIENCY (SCID) MICE/, Blood, 86(10), 1995, pp. 2278-2278
Authors:
PETERS WP
ROSS M
VREDENBURGH JJ
MEISENBERG B
MARKS LB
WINER E
KURTZBERG J
BAST RC
JONES R
SHPALL E
WU K
ROSNER G
GILBERT C
MATHIAS B
CONIGLIO D
PETROS W
HENDERSON IC
NORTON L
WEISS RB
BUDMAN D
HURD D
Citation: Wp. Peters et al., HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW SUPPORT AS CONSOLIDATION AFTER STANDARD-DOSE ADJUVANT THERAPY FOR HIGH-RISK PRIMARY BREAST-CANCER, Journal of clinical oncology, 11(6), 1993, pp. 1132-1143